Pseudomonas Aeruginosa Antibody (1010/287) - BSA Free

• Reactivity: Ba
• Applications: ELISA
• Clone: 1010/287
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Unconjugated
• Format: BSA Free
• Concentration: 1 mg/ml

Pseudomonas Aeruginosa Antibody (1010/287) - BSA Free Summary

• Description: Novus Biologicals Mouse Pseudomonas Aeruginosa Antibody (1010/287) - BSA Free (NBP1-45176) is a monoclonal antibody validated for use in ELISA. Anti-Pseudomonas Aeruginosa Antibody: Cited in 1 publication. All Novus Biologicals antibodies are covered by our 100% guarantee.
• Immunogen: P. aeruginosa serotype 6
• Specificity: AERUGINOSA
• Isotype: IgG2a
• Clonality: Monoclonal
• Host: Mouse
• Purity: Protein G purified

Applications/Dilutions

• Dilutions:
  • ELISA 1:100-1:2000
• Application Notes: This antibody does not work in Immunohistochemistry - Frozen, Immunohistochemistry - Paraffin, or Immunohistochemistry- Resin.

Packaging, Storage & Formulations

• Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
• Buffer: PBS
• Preservative: 0.09% Sodium Azide
• Concentration: 1 mg/ml
• Purity: Protein G purified

Alternate Names for Pseudomonas Aeruginosa Antibody (1010/287) - BSA Free

• Pseudomonas aeruginosa 9

Background

Pseudomonas aeruginosa is Gram-negative, aerobic, rod-shaped bacteria with unipolar motility. An opportunistic human pathogen, P. aeruginosa is also an opportunistic pathogen of plants. P. aeruginosa bacteria are clinically important because they are resistant to most antibiotics and they are capable of surviving in conditions that few other organisms can tolerate. Pseudomonas is often encountered in hospital and clinical work because it is a major cause of hospital acquired (nosocomal) infections. Its main targets are immunocompromised individuals, burn victims, and individuals on respirators or with indwelling catheters. Additionally, these pathogens colonize the lungs of cystic fibrosis patients. P. aeruginosa is often identified by its pearlescent appearance and grape-like odor in vitro. Definitive clinical identification of P. aeruginosa includes identifying the production of both pyocyanin and fluorescein as well as its ability to grow at 42 C. P. aeruginosa is capable of growth in diesel and jet fuel, where it is known as hydrocarbon utilizing microorganisms (or "HUM bugs"), causing microbial corrosion. It creates dark gellish mats sometimes improperly called "algae".

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for Pseudomonas Aeruginosa Antibody (NBP1-45176)(1)

Publication using NBP1-45176

• Peng H, Rossetto D, Mansy SS et al. Treatment of wound infections in a mouse model using Zn2+-releasing phage bound to gold nanorods ACS Nano 2022-01-01 [PMID: 35239330]

FAQs for Pseudomonas Aeruginosa Antibody (NBP1-45176). (Showing 1 - 1 of 1 FAQ).

1. We are specifically looking for P. aeruginosa antibodies raised against the soluble proteins or the outer cell proteins. Do you have anything you can recommend?
   • I would recommend NB110-40711 and NB110-17299, as they were both raised against an outer membrane preparation of Pseudomonas Aeruginosa.